Lanean...
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?
Pancreatic adenocarcinoma (usually referred to as pancreatic cancer) is a highly lethal and aggressive malignancy with a disease-related mortality almost equaling its incidence, and one of the most challenging cancers to treat. The notorious resistance of pancreatic cancer not only to conventional c...
Gorde:
| Argitaratua izan da: | World J Gastrointest Oncol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606172/ https://ncbi.nlm.nih.gov/pubmed/26483872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v7.i10.172 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|